TrialDiabetes2013

Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia.

Tricia M Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.